Monitor for additional Form 4 filings and any upcoming corporate events (earnings, pipeline updates) that could explain the selling. The stock's high analyst bullishness (94% buy ratings) contrasts with insider behavior, creating a potential divergence to watch.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 8 $51.36entry
- T+1 · 5mo ago +0.53%α +0.82% · $51.63
- T+5 · 5mo ago +15.87%α +13.76% · $59.51
- T+20 · 4mo ago +21.32%α +19.69% · $62.31
- T+60 · 3mo ago +7.63%α +4.58% · $55.28
Price Chart
How similar events traded
Executive Summary
Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on June 5, 2026, indicating intent to sell 22,491 shares of common stock valued at approximately $1.15 million. The filing also reveals a pattern of recent sales totaling over 160,000 shares in the prior two weeks, suggesting a sustained insider selling campaign rather than a one-off liquidity event.
Key Facts
- Officer Dennis Mulroy filed Form 144 to sell 22,491 shares valued at ~$1.15 million.
- The filing also discloses 13 prior sales between May 15 and June 4, 2026, totaling ~160,422 shares for ~$8.7 million.
- The proposed sale is attributed to a stock option exercise, but the aggregate selling pattern is substantial.
- Market cap is ~$1.5B, so the total disclosed sales (~$9.9M) represent ~0.66% of market cap.
- No other insider activity reported in the last 30 days per market data snapshot.
Financial Impact
Total disclosed insider sales of ~$9.9 million over the past three weeks, with the latest 144 adding ~$1.15 million.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed, but the pattern of recent completed sales is confirmed.
- The selling could be for personal diversification or tax planning, not necessarily a reflection of company outlook.
- High analyst consensus may already be priced in, and insider selling could precede negative news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005723 |
| Document: 0001950047-26-005723-index.html | 0001950047-26-005723 |
| Document: 0001950047-26-005723.txt | 0001950047-26-005723 |
Track record
28 reports on ANAB
10 of 18 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 18 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
- Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
- Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
- Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
- Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
- Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers